(Q33437280)

26 July 2017

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine (English)

1 reference

Venezuelan equine encephalitis

26 July 2017

1 reference

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis virus

object named as

Venezuelan equine encephalitis virus

1 reference

9

Connie S Schmaljohn

1 reference

26 July 2017

1

Lesley C Dupuy

1 reference

26 July 2017

4

Michelle J Richards

1 reference

26 July 2017

6

Russell Bakken

1 reference

26 July 2017

Christopher P Locher

2

1 reference

26 July 2017

Madan Paidhungat

3

1 reference

26 July 2017

Cathleen M Lind

5

1 reference

26 July 2017

Michael D Parker

7

1 reference

26 July 2017

Robert G Whalen

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

9 May 2009

1 reference

26 July 2017

1 reference

26 July 2017

27

1 reference

26 July 2017

4152-4160

1 reference

26 July 2017

31

1 reference

Clinical recognition and management of patients exposed to biological warfare agents

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Anticipatory evolution and DNA shuffling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Optimization of protein therapeutics by directed evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

DNA shuffling of a family of genes from diverse species accelerates directed evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Rapid evolution of a protein in vitro by DNA shuffling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

DNA shuffling and screening strategies for improving vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Particle-mediated DNA vaccine delivery to the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Placement of the structural proteins in Sindbis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Functional characterization of the Sindbis virus E2 glycoprotein by transposon linker-insertion mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.049

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.04.049

1 reference

26 July 2017

1 reference